Health & Life Sciences

Saudi Arabia’s health and life sciences sectors are undergoing a transformation driven by the Health Sector Transformation Programme and the National Biotechnology Strategy, creating significant opportunities for private sector investment. The government plans to invest $66bn in health care infrastructure between 2021 and 2030, with up to 65% from the private sector. This includes expanding hospitals, improving facilities and boosting digitalisation and telemedicine services. The Kingdom’s Vision 2030 emphasises world-class health care, with the pharmaceuticals sector benefitting from innovation and investment. In 2023 Saudi Arabia had 510 hospitals and extensive health care facilities. The shift towards private health care, alongside continued growth, positions Saudi Arabia as an attractive market for health care and medical research and development in the coming years. This chapter also contains interviews with Fahad bin Abdurrahman Al Jalajel, Minister of Health; Prince Sultan bin Salman Al Saud, Chairman, King Salman Centre for Disability Research; and Fahad Al Shebel, CEO, National Unified Procurement Company.